Press Release – New York, NY – December 30, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of BiondVax …
Sichenzia Ross Ference LLP Represents Zynex, Inc. in its $31.0 Million Acquisition of Kestrel Labs
Press Release – New York, NY – December 23, 2021 – Sichenzia Ross Ference LLP announced today that its mergers and acquisitions team represented Zynex, Inc. (NASDAQ ZYXI) in its acquisition of Kestrel …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $25 Million Initial Public Offering for Cingulate, Inc.
Press Release – New York, NY – December 13, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an initial public offering of Cingulate …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $77 Million Public Offering for Nisun International
Press Release – New York, NY – December 16, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Nisun …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $172.5 Million Upsized Public Offering Underwritten by Goldman Sachs and Jefferies
Press Release – New York, NY – December 14, 2021 – Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $13.7 Million Underwritten Public Offering for Tantech Holdings Ltd.
Press Release – New York, NY – December 9, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Tantech …
